Soy protein
Also called soy protein isolate, soy protein concentrate, soybean protein, textured soy protein, soya protein.
Best grade B across 6 graded outcomes Other Last checked
The short answer
From 13 sourcesSoy protein is a plant protein powder. A meta-analysis of 43 trials found a median 25 g a day lowered LDL cholesterol by about 4.8 mg/dL over a median 6 weeks. For muscle, nine studies with 266 people found soy and animal protein gave similar strength and lean mass gains with resistance training.
Every graded outcome on this page
6 rows · line = participants- BGrade BStrength and lean body mass with resistance trainingSoy protein vs animal protein supplementsn 266
- BGrade BLDL and total cholesterolSoy protein vs non-soy proteinn 43
- CGrade CBlood pressure in postmenopausal womenSoy protein (with isoflavones)n 1,551
- CGrade CLean body mass and strength in young adultsWhey or soy protein concentrate or isolaten 261
- CGrade CCirculating reproductive hormonesSoy protein or isoflavonesn 47
- DGrade DBreast cancer survival and recurrence (observational)Dietary soy and isoflavone intake, highest vs lowestn 37,275
- 3 more graded outcomes, in the evidence chapter
Key facts
- LDL cholesterol
- Median 25 g/day for a median 6 weeks: LDL -4.76 mg/dL and total cholesterol -6.41 mg/dL vs non-soy protein (43 trials)2
- Muscle vs animal protein
- Soy and animal protein gave similar strength and lean mass gains with resistance training (9 studies, 266 participants)3
- Blood pressure
- In postmenopausal women, 25 g/day or more lowered systolic pressure by 4.62 mmHg (12 trials, 1,551 women)5
- Hormones
- Soy or isoflavones lowered FSH and LH by about 20% in premenopausal women; in postmenopausal women estradiol showed only a non-significant 14% rise (47 studies)6
- Protein quality
- Mean DIAAS 84.5 and PDCAAS 85.6 across soy products; isolate scored below soymilk8
- Label claim
- FDA proposed revoking the soy protein and heart disease health claim in October 2017; it remained listed as authorized on FDA's page last updated March 202410
What it is
Soy protein is the protein from soybeans, sold as isolate or concentrate powders; it also carries some soy isoflavones.
How it works
ProposedThe NIH fact sheet notes that soy protein lacks the essential amino acid methionine and may lose some cysteine and lysine in processing, yet a quantitative review scored soy products at a mean DIAAS of 84.5. Its cholesterol effect is small and its mechanism is not settled; the blood pressure benefit in one meta-analysis was linked by the authors to the isoflavone component.15
Forms, side by side
2 forms named in our sources. The rest show what our data holds, and say plainly where it holds nothing yet.
Soy protein forms compared
2 forms| 2 forms | Isolate | Concentrate |
|---|---|---|
| Absorption in people | The NIH fact sheet says soy lacks the essential amino acid methionine and may lose some cysteine and lysine in processing. In a quantitative review, isolate scored below soymilk on DIAAS, and heat or moisture during processing could raise or lower scores.18 | Ranked just below soymilk for DIAAS among the soy products in the quantitative review; scores varied widely within each group.8 |
| GI tolerance | No product-specific safety signal in the cited meta-analyses.23 | Not reported separately in the cited abstracts.8 |
| Studied for | Cholesterol (median 25 g/day) and muscle with resistance training | Protein quality comparisons; used alongside isolate in muscle trials |
- Soy protein isolate
- Absorption in people
- The NIH fact sheet says soy lacks the essential amino acid methionine and may lose some cysteine and lysine in processing. In a quantitative review, isolate scored below soymilk on DIAAS, and heat or moisture during processing could raise or lower scores.18
- Studied for
- Cholesterol (median 25 g/day) and muscle with resistance training
- Soy protein concentrate
What the human research says
Human trials only, one row per outcome. The form line shows what each trial actually tested. Grades follow our evidence-grading policy.
Trial map
6 graded outcomes, largest study first6 graded outcomes: 2 improved, 2 mixed, 2 no effect. The largest, a 2019 meta-analysis of 37,275 people on breast cancer survival and recurrence (observational), found mixed results.
1Breast cancer survival and recurrence (observational)
Mixed · Grade D · Meta-analysis, 37,275 people, 2019
Women with breast cancer in 12 observational articles (37,275 women)
Dose, result and source| Outcome | Found | People | Study | Who was studied |
|---|---|---|---|---|
| Breast cancer survival and recurrence (observational) | Mixed | 37,275 | Grade D · Meta-analysis, 2019 | Women with breast cancer in 12 observational articles (37,275 women) |
| Blood pressure in postmenopausal women | Improved | 1,551 | Grade C · Meta-analysis, 2017 | Postmenopausal women in 12 randomized trials |
| Strength and lean body mass with resistance training | No effect | 266 | Grade B · Meta-analysis, 2018 | Participants in 9 studies of at least 6 weeks; 5 compared whey with soy and 4 compared soy with beef, milk or dairy protein |
| Lean body mass and strength in young adults | No effect | 261 | Grade C · Meta-analysis, 2026 | Healthy adults aged 18 to 30 doing resistance training, 12 studies |
| Circulating reproductive hormones | Mixed | 47 | Grade C · Meta-analysis, 2009 | Pre- and postmenopausal women in 47 trials of 4 weeks or longer (11 premenopausal, 35 postmenopausal, 1 perimenopausal) |
| LDL and total cholesterol | Improved | 43 | Grade B · Meta-analysis, 2019 | Adults with baseline LDL cholesterol of 110 to 201 mg/dL in the 46 controlled trials FDA identified (43 had usable data) |
Every graded row
6 rowsShowing 6 of 6 outcomes. Human trials only.
BGrade BStrength and lean body mass with resistance trainingPerformanceNo effectMeta-analysis
n 266 · 2018
Both groups gained strength with no difference between them (bench press p = 0.90; squat p = 0.64). Lean mass change did not differ between whey and soy (p = 0.96), and soy vs other proteins also showed no difference (p = 0.80).
- Design
- Meta-analysis, n = 266, 2018
- Population
- Participants in 9 studies of at least 6 weeks; 5 compared whey with soy and 4 compared soy with beef, milk or dairy protein
- Form
- Soy protein vs animal protein supplements
- Dose
- Varied by study
- Duration
- 6 weeks or longer
- Source
- Reference 3 · PubMed 29722584 (opens PubMed)
BGrade BLDL and total cholesterolHeartImprovedMeta-analysis
n 43 · 2019
LDL fell by 4.76 mg/dL (95% CI -6.71 to -2.80; I2 = 55%) and total cholesterol by 6.41 mg/dL (95% CI -9.30 to -3.52; I2 = 74%). About 75% of trials showed an LDL reduction, though only a minority were individually significant; there was no dose-response.
- Design
- Meta-analysis, n = 43, 2019
- Population
- Adults with baseline LDL cholesterol of 110 to 201 mg/dL in the 46 controlled trials FDA identified (43 had usable data)
- Form
- Soy protein vs non-soy protein
- Dose
- Median 25 g/day
- Duration
- Median 6 weeks
- Source
- Reference 2 · PubMed 31006811 (opens PubMed)
CGrade CBlood pressure in postmenopausal womenHeartImprovedMeta-analysis
n 1,551 · 2017
Overall, systolic pressure fell 3.03 mmHg (95% CI -5.03 to -1.02) and diastolic 0.71 mmHg. At 25 g/day or more the drops were 4.62 and 1.63 mmHg; below 25 g/day there was no significant effect. The authors link the benefit to isoflavones.
- Design
- Meta-analysis, n = 1,551, 2017
- Population
- Postmenopausal women in 12 randomized trials
- Form
- Soy protein (with isoflavones)
- Dose
- 25 g/day or more in the benefit subgroup
- Duration
- Varied by trial
- Source
- Reference 5 · PubMed 28675204 (opens PubMed)
CGrade CLean body mass and strength in young adultsPerformanceNo effectMeta-analysis
n 261 · 2026
Neither whey nor soy significantly changed lean body mass. Protein supplements raised peak plasma essential amino acids, and whey improved bench press (MD 8.87) and squat (MD 9.60); the abstract gives no soy strength result.
- Design
- Meta-analysis, n = 261, 2026
- Population
- Healthy adults aged 18 to 30 doing resistance training, 12 studies
- Form
- Whey or soy protein concentrate or isolate
- Dose
- Varied by study
- Duration
- Varied by study
- Source
- Reference 4 · PubMed 41454445 (opens PubMed)
CGrade CCirculating reproductive hormonesHealthy agingMixedMeta-analysis
n 47 · 2009
In premenopausal women estradiol, estrone and SHBG were unchanged, FSH and LH fell about 20% and cycle length rose 1.05 days. In postmenopausal women there were no significant effects, with a non-significant 14% rise in total estradiol (p = 0.07).
- Design
- Meta-analysis, n = 47, 2009
- Population
- Pre- and postmenopausal women in 47 trials of 4 weeks or longer (11 premenopausal, 35 postmenopausal, 1 perimenopausal)
- Form
- Soy protein or isoflavones
- Dose
- Varied by trial
- Duration
- 4 weeks or longer
- Source
- Reference 6 · PubMed 19299447 (opens PubMed)
DGrade DBreast cancer survival and recurrence (observational)Healthy agingMixedMeta-analysis
n 37,275 · 2019
Pre-diagnosis intake was linked to a lower risk of death (HR 0.84, 95% CI 0.71 to 0.98) but not breast cancer-specific death. Post-diagnosis intake showed no significant link with overall survival (HR 0.80, 0.62 to 1.04); both were linked to lower recurrence.
- Design
- Meta-analysis, n = 37,275, 2019
- Population
- Women with breast cancer in 12 observational articles (37,275 women)
- Form
- Dietary soy and isoflavone intake, highest vs lowest
- Dose
- Dietary intake, not supplements
- Duration
- Observational follow-up
- Source
- Reference 7 · PubMed 30382332 (opens PubMed)
What the numbers add up to
Each point is worked out from the data and the sources numbered on this page, with the arithmetic shown under it. It adds no new data and is not medical advice.
A small cholesterol effect, not a drug
For muscle, soy matches animal protein rather than beating it
Blood pressure results may be about isoflavones
The blood pressure drop appeared only at 25 g/day or more, and the authors attributed it to the isoflavones that come with soy protein.5
Studied doses
Doses used in research, shown against the official limits. They describe the studies, not a recommendation for you.
Studied doses in research, not advice. These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.
Doses studied in human trials
NIH ODS updated Apr 1, 2024Doses studied in human trials ranged from about 25 g of soy protein a day (the median in the cholesterol meta-analysis, over a median 6 weeks); the muscle trials lasted 6 weeks or longer and their doses are not given in the abstracts. These are research doses, not advice.253
Intake reference: Protein RDA: 0.8 g/kg/day for healthy adults and 0.85 g/kg/day for adolescents. The NIH fact sheet notes that athletes may need more; it does not set an upper limit for protein.1 The Food and Nutrition Board has not set a UL for protein but advises caution with high intakes from foods plus supplements because data on adverse effects are limited. NIH ODS fact sheet (updated April 1, 2024).
Interactions and safety
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
What Soy protein meets
1 cited rowMedicines 1
Supplements and foods 0
No supplement rows in our sources.
- Drug label or FDA notice
Choose a medicine or supplement above to read its cited rows here.
Also cited:
Levothyroxine
Drug labelDrug label or FDA notice
Levothyroxine, for example Thyroid hormone tablets such as Synthroid: The levothyroxine label lists soybean flour among foods that may bind levothyroxine in the gut and decrease its absorption, which can require dose adjustment. Soy protein powder itself was not tested; people on thyroid hormone should ask their prescriber about timing.
Source 13, AbbVie via DailyMed (U.S. National Library of Medicine) (2024)
Interactions
1 agent| Agent | What the source says | Evidence |
|---|---|---|
| Medicines1 | ||
| Levothyroxinee.g. Thyroid hormone tablets such as Synthroid | The levothyroxine label lists soybean flour among foods that may bind levothyroxine in the gut and decrease its absorption, which can require dose adjustment. Soy protein powder itself was not tested; people on thyroid hormone should ask their prescriber about timing.13 | Drug label |
Check with what you take
Kept on this device onlyAdd what you take. We list every interaction our evidence profiles cite between Soy protein and your picks, and between your picks.
- Loading names…
Add a supplement or medicine you take to check it against Soy protein.
Starting from one medicine? The interaction checker rates how serious each pair is, on a curated list of 19 entries for 11 medicines. This cabinet has no severity rating: it lists every interaction row our supplement pages cite.
Who should be careful
4 groups- Soy allergy
- Soybeans are a major US food allergen, and labels must name soy as the allergen source. People with a soy allergy should avoid soy protein products.11
- Hormone-sensitive conditions
- Soy products contain isoflavones and changed FSH, LH and cycle length in premenopausal women in a meta-analysis. The breast cancer data are observational and about dietary soy, not powders, so anyone with a hormone-sensitive condition should ask their care team.67
- Kidney disease
- A systematic review in healthy adults found protein above the RDA consistent with normal kidney function in the short term, but it excluded people with kidney disease and most studies ran under 6 months.12
- Pregnancy, breastfeeding and children
- No soy protein supplement studies in these groups were found in the sources reviewed.1
How to read the label
What to check on the Supplement Facts panel.
How to read the label
4 checksCheck protein grams per serving
The cholesterol meta-analysis used a median of 25 g of soy protein a day, so compare grams of soy protein, not scoop size.2
Read the allergen statement
FDA requires packaged foods and dietary supplements to declare soy, in the ingredient list or in a 'Contains' statement.11
Read heart-health wording carefully
FDA proposed in October 2017 to revoke its authorized soy protein and heart disease claim, saying the evidence no longer met its standard; the claim was still listed on FDA's page updated March 2024.10
Look for a blend
The NIH fact sheet notes that many protein products combine sources; soy lacks methionine, which other protein sources in a blend can supply.1
Frequently asked questions
Short answers to common questions; the numbers link to the sources below.
Common questions
6 answersDoes soy protein lower cholesterol?
Modestly. A median 25 g a day for a median 6 weeks lowered LDL by 4.76 mg/dL in a 43-trial meta-analysis, roughly 3 to 4%.2
Is soy protein as good as whey for muscle?
How much soy protein did studies use?
Does soy protein affect hormones?
In a 47-study meta-analysis, soy or isoflavones lowered FSH and LH about 20% in premenopausal women; in postmenopausal women estradiol rose a non-significant 14%.6
Is soy a complete protein?
Can soy protein carry a heart health claim?
FDA authorized the claim in 1999 and proposed revoking it in October 2017. It was still listed as authorized on FDA's page last updated March 2024.10
Sources
13 sources: trial abstracts, NIH fact sheets and reference databases. Numbers in the text link here.
Sources cited on this page
13 sources- 1Exercise and Athletic Performance: Health Professional Fact SheetFact sheet NIH Office of Dietary Supplements, 2024 · ods.od.nih.gov
- 2A Meta-Analysis of 46 Studies Identified by the FDA Demonstrates that Soy Protein Decreases Circulating LDL and Total Cholesterol Concentrations in Adults.Meta-analysis J Nutr, 2019 · PMID 31006811
- 3No Difference Between the Effects of Supplementing With Soy Protein Versus Animal Protein on Gains in Muscle Mass and Strength in Response to Resistance Exercise.Meta-analysis Int J Sport Nutr Exerc Metab, 2018 · PMID 29722584
- 4The Impact of Whey and Soy Protein Supplementation on Resistance Training in Young Adults: A Systematic Review and Meta-Analysis.Meta-analysis J Diet Suppl, 2026 · PMID 41454445
- 5Effect of soybean protein on blood pressure in postmenopausal women: a meta-analysis of randomized controlled trials.Meta-analysis Food Funct, 2017 · PMID 28675204
- 6Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis.Meta-analysis Hum Reprod Update, 2009 · PMID 19299447
- 7Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis.Meta-analysis Eur J Nutr, 2019 · PMID 30382332
- 8Protein quality of soy and the effect of processing: A quantitative review.Review Front Nutr, 2022 · PMID 36238463
- 9Comparative Efficacy of Different Protein Supplements on Muscle Mass, Strength, and Physical Indices of Sarcopenia among Community-Dwelling, Hospitalized or Institutionalized Older Adults Undergoing Resistance Training: A Network Meta-Analysis of Randomized Controlled Trials.Meta-analysis Nutrients, 2024 · PMID 38612975
- 10Authorized Health Claims That Meet the Significant Scientific Agreement (SSA) Standard (lists 21 CFR 101.82 soy protein and CHD, with the October 2017 proposal to revoke it)Fact sheet U.S. Food and Drug Administration, 2024 · fda.gov
- 11Food Allergies (soybeans are one of nine major food allergens; allergen source must be declared on packaged foods and dietary supplements)Fact sheet U.S. Food and Drug Administration, 2026 · fda.gov
- 12A Systematic Review of Renal Health in Healthy Individuals Associated with Protein Intake above the US Recommended Daily Allowance in Randomized Controlled Trials and Observational Studies.Systematic review Adv Nutr, 2018 · PMID 30032227
- 13SYNTHROID (levothyroxine sodium) tablets: prescribing information (7.9 Drug-Food Interactions)Label AbbVie via DailyMed (U.S. National Library of Medicine), 2024 · dailymed.nlm.nih.gov
What changed
Every dated change to this page: what changed, who made it and why.
Change log
2 entries| Date | Change | Who and why |
|---|---|---|
| interactions | Adversarial review: added the levothyroxine interaction from the Synthroid label (section 7.9 lists soybean flour among foods that decrease absorption; label read via openFDA, effective 2024-02-20). Hormone key fact and FAQ now report the non-significant 14% estradiol rise in postmenopausal women instead of "no change"; heart-claim insight reworded to the reason FDA gave. FDA health-claims page re-opened (content current as of 2024-03-28). | Writer: Kymata Health EditorialTrigger: adversarial review |
| all | Initial editorial evidence review. Every PMID checked against NCBI E-utilities esummary (title, year, journal) and each cited abstract read; figures taken from the abstracts. Regulatory status from FDA's authorized health claims page (content dated 2024-03-28) and its allergens page (2026-03-11); the final-rule status of the 2017 revocation proposal was not confirmed beyond that page. | Writer: Kymata Health EditorialTrigger: new page |
Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.